• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在循证医学时代发展中医药:当前证据与挑战。

Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.

机构信息

Traditional Medicine Information Service, Department of Pharmacy, Singapore General Hospital, Singapore.

Department of Haematology, Singapore General Hospital, Academia, 20 College Road, Singapore 169856.

出版信息

Evid Based Complement Alternat Med. 2015;2015:425037. doi: 10.1155/2015/425037. Epub 2015 Apr 8.

DOI:10.1155/2015/425037
PMID:25949261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4407626/
Abstract

Evidence-based medicine (EBM), by integrating individual clinical expertise with the best available clinical evidence from systematic research, has in recent years been established as the standard of modern medical practice for greater treatment efficacy and safety. Traditional Chinese Medicine (TCM), on the other hand, evolved as a system of medical practice from ancient China more than 2000 years ago based on empirical knowledge as well as theories and concepts which are yet to be mapped by scientific equivalents. Despite the expanding TCM usage and the recognition of its therapeutic benefits worldwide, the lack of robust evidence from the EBM perspective is hindering acceptance of TCM by the Western medicine community and its integration into mainstream healthcare. For TCM to become an integral component of the healthcare system so that its benefits can be rationally harnessed in the best interests of patients, it is essential for TCM to demonstrate its efficacy and safety by high-level evidence in accordance with EBM, though much debate remains on the validity and feasibility of applying the EBM model on this traditional practice. This review aims to discuss the current status of research in TCM, explore the evidences available on its efficacy and safety, and highlight the issues and challenges faced in applying EBM to TCM.

摘要

循证医学(EBM)通过整合个体临床专业知识和系统研究中获得的最佳临床证据,近年来已成为现代医学实践的标准,以提高治疗效果和安全性。另一方面,中医药(TCM)是一种从 2000 多年前的中国古代发展而来的医疗实践体系,其基于经验知识以及尚未被科学等同物所描绘的理论和概念。尽管 TCM 的使用不断扩大,其治疗益处也在全球范围内得到认可,但由于缺乏 EBM 视角的有力证据,西医界对 TCM 的接受程度以及将其纳入主流医疗保健方面受到阻碍。为了使 TCM 成为医疗保健系统的一个组成部分,以便为了患者的最佳利益合理利用其益处,TCM 必须按照 EBM 用高级别的证据证明其疗效和安全性,尽管关于在这种传统实践中应用 EBM 模型的有效性和可行性仍存在很多争议。本文旨在讨论 TCM 的研究现状,探讨其疗效和安全性方面的现有证据,并强调将 EBM 应用于 TCM 所面临的问题和挑战。

相似文献

1
Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.在循证医学时代发展中医药:当前证据与挑战。
Evid Based Complement Alternat Med. 2015;2015:425037. doi: 10.1155/2015/425037. Epub 2015 Apr 8.
2
Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice.中医药标准化及其临床实践证据评估
Drug Discov Ther. 2011 Dec;5(6):261-5. doi: 10.5582/ddt.2011.v5.6.261.
3
A brief discussion on evidence-based clinical research of traditional Chinese medicine.关于中医循证临床研究的简要讨论。
Ann Palliat Med. 2021 Dec;10(12):12937-12944. doi: 10.21037/apm-20-697. Epub 2020 Aug 20.
4
[Development of integrated traditional Chinese and western medicine and change of medical policy in China].[中国中西医结合的发展与医疗政策的变化]
Uisahak. 1999;8(2):207-32.
5
[Evidence-based Chinese medicine:theory and practice].[循证中医学:理论与实践]
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):1-7. doi: 10.19540/j.cnki.cjcmm.20171127.001.
6
[Precise application of Traditional Chinese Medicine in minimally-invasive techniques].[中医在微创技术中的精准应用]
Zhongguo Gu Shang. 2018 Jun 25;31(6):493-496. doi: 10.3969/j.issn.1003-0034.2018.06.001.
7
Integration of traditional Chinese medicine and Western medicine in the era of precision medicine.精准医学时代的中西医结合。
J Integr Med. 2017 Jan;15(1):1-7. doi: 10.1016/S2095-4964(17)60314-5.
8
Development in and challenge for traditional Chinese medicine in Australia.澳大利亚中医药的发展与挑战
J Altern Complement Med. 2009 Jun;15(6):685-8. doi: 10.1089/acm.2008.0325.
9
[Key points of protocol design on clinical therapeutic research of traditional Chinese medicine].[中医临床治疗研究方案设计要点]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Feb;27(2):171-3.
10
[Ten challenging issues in the clinical research of Chinese medicine].[中医临床研究中的十个挑战性问题]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 May;29(5):389-91.

引用本文的文献

1
The Role of Gut Microbiota in the Modulation of Pulmonary Immune Response to Viral Infection Through the Gut-Lung Axis.肠道微生物群通过肠-肺轴在调节肺部对病毒感染的免疫反应中的作用。
J Inflamm Res. 2025 Aug 26;18:11755-11781. doi: 10.2147/JIR.S525880. eCollection 2025.
2
Characteristics and Related Factors of Chinese Herbal Medicine Use in Middle-Aged and Older Patients with Cardiovascular Disease in China: A Cross-Sectional Study.中国心血管疾病中老年患者使用中草药的特征及相关因素:一项横断面研究
Patient Prefer Adherence. 2025 Aug 25;19:2623-2633. doi: 10.2147/PPA.S538773. eCollection 2025.
3
Role of borneol as enhancer in drug formulation: A review.冰片在药物制剂中作为增溶剂的作用:综述。
Chin Herb Med. 2024 May 17;17(3):473-483. doi: 10.1016/j.chmed.2024.04.003. eCollection 2025 Jul.
4
Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms.中医与阿尔茨海默病的桥梁:肠道微生物群在多靶点治疗机制中的关键作用
Front Pharmacol. 2025 Jun 27;16:1630205. doi: 10.3389/fphar.2025.1630205. eCollection 2025.
5
Multi-level association rule mining and network pharmacology to identify the polypharmacological effects of herbal materials and compounds in traditional medicine.多层次关联规则挖掘与网络药理学用于识别传统医学中草药和化合物的多药效应。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf328.
6
Traditional Chinese medicine and modern technology: Network pharmacology and omics sequencing in gastric cancer.传统中医与现代技术:胃癌中的网络药理学与组学测序
World J Gastrointest Oncol. 2025 Mar 15;17(3):102077. doi: 10.4251/wjgo.v17.i3.102077.
7
Polyphenols for the Prevention or Management of Preeclampsia: A Systematic Review and Meta-Analysis.用于预防或治疗子痫前期的多酚类物质:一项系统评价与荟萃分析
BJOG. 2025 Jun;132(7):867-879. doi: 10.1111/1471-0528.18106. Epub 2025 Mar 3.
8
Study on the application effect of traditional Chinese medicine syndrome differentiation nursing in the rehabilitation of language function in patients with stroke.中医辨证施护在脑卒中患者语言功能康复中的应用效果研究
Medicine (Baltimore). 2025 Feb 21;104(8):e41344. doi: 10.1097/MD.0000000000041344.
9
Similar but Different Three Major Traditional Medicines in East Asia: A Bibliometric Analysis.东亚三种主要传统医学的异同:文献计量分析
Chin J Integr Med. 2025 Apr;31(4):372-378. doi: 10.1007/s11655-025-4110-8. Epub 2025 Jan 10.
10
Lipid-lowering agent preferences among patients with hypercholesterolemia: a focus group study.高胆固醇血症患者对降脂药物的偏好:一项焦点小组研究。
J Pharm Policy Pract. 2024 Dec 9;17(1):2421261. doi: 10.1080/20523211.2024.2421261. eCollection 2024.

本文引用的文献

1
The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012.中药治疗随机临床试验报告质量:2005 年至 2012 年中国知识基础设施数据库收录文章的系统评价。
BMC Complement Altern Med. 2014 Sep 26;14:362. doi: 10.1186/1472-6882-14-362.
2
Pain management with acupuncture in osteoarthritis: a systematic review and meta-analysis.针灸治疗骨关节炎疼痛的管理:系统评价和荟萃分析。
BMC Complement Altern Med. 2014 Aug 23;14:312. doi: 10.1186/1472-6882-14-312.
3
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.TCMSP:一个草药药物发现系统药理学数据库。
J Cheminform. 2014 Apr 16;6:13. doi: 10.1186/1758-2946-6-13. eCollection 2014.
4
Impact of chinese herbal medicine on american society and health care system: perspective and concern.中草药对美国社会和医疗保健系统的影响:观点和关注。
Evid Based Complement Alternat Med. 2014;2014:251891. doi: 10.1155/2014/251891. Epub 2014 Feb 27.
5
Bench to bed evidences for pharmacokinetic and pharmacodynamic interactions involving oseltamivir and chinese medicine.涉及奥司他韦和中药的药代动力学和药效学相互作用的从实验室到病床的证据。
Evid Based Complement Alternat Med. 2014;2014:354172. doi: 10.1155/2014/354172. Epub 2014 Jan 9.
6
Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial.中药三七可降低糖耐量受损向糖尿病的进展:一项双盲、随机、安慰剂对照、多中心试验。
J Clin Endocrinol Metab. 2014 Feb;99(2):648-55. doi: 10.1210/jc.2013-3276. Epub 2014 Jan 16.
7
Effects of MLC601 on early vascular events in patients after stroke: the CHIMES study.MLC601 对中风后患者早期血管事件的影响:CHIMES 研究。
Stroke. 2013 Dec;44(12):3580-3. doi: 10.1161/STROKEAHA.113.003226. Epub 2013 Oct 17.
8
Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.马兜铃酸的全基因组突变特征及其作为筛选工具的应用。
Sci Transl Med. 2013 Aug 7;5(197):197ra101. doi: 10.1126/scitranslmed.3006086.
9
Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.中药神经辅助剂对中风康复的疗效:一项双盲、安慰剂对照、随机研究。
Stroke. 2013 Aug;44(8):2093-100. doi: 10.1161/STROKEAHA.113.002055. Epub 2013 Jun 18.
10
The quest for modernisation of traditional Chinese medicine.探索中医现代化之路。
BMC Complement Altern Med. 2013 Jun 13;13:132. doi: 10.1186/1472-6882-13-132.